The rulings mean the foundation will continue to control primarySo what is really going on here is a good old fashioned fight among capitalists over who gets to eat the biggest piece of the pie, as I pointed out here at SHS last year.
intellectual property rights to embryonic stem cell research in the United States. If that research leads to successful medical products or procedures before the patents expire in 2015, the school could win royalties.
The Foundation for Taxpayer and Consumer Rights and the Public Patent Foundation, which asked the patent office to throw out the patents in 2006, argued that their enforcement slowed U.S. stem cell research and drove some investment overseas.
Typique.
Time is short, so I’ll be direct: FIRST THINGS needs you. And we need you by December 31 at 11:59 p.m., when the clock will strike zero. Give now at supportfirstthings.com.
First Things does not hesitate to call out what is bad. Today, there is much to call out. Yet our editors, authors, and readers like you share a greater purpose. And we are guided by a deeper, more enduring hope.
Your gift of $50, $100, or even $250 or more will bring this message of hope to many more people in the new year.
Make your gift now at supportfirstthings.com.
First Things needs you. I’m confident you’ll answer the call.
